{"id":"https://openalex.org/W2789214860","doi":"https://doi.org/10.1080/03007995.2018.1430220","title":"Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study","display_name":"Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study","alternate_titles":[],"publication_year":2018,"publication_date":"2018-01-25","ids":{"openalex":"https://openalex.org/W2789214860","doi":"https://doi.org/10.1080/03007995.2018.1430220","mag":"2789214860","pmid":"https://pubmed.ncbi.nlm.nih.gov/29343128"},"language":"en","primary_location":{"id":"doi:10.1080/03007995.2018.1430220","doi":"https://doi.org/10.1080/03007995.2018.1430220","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2018.1430220","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1430220?needAccess=true&role=button","source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2789214860"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1430220?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110533970","display_name":"Mary Hobart","orcid":"https://orcid.org/0009-0006-0216-1483","observed_orcids":["https://orcid.org/0009-0006-0216-1483"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mary Hobart","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021739236","display_name":"Aleksandar Skuban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aleksandar Skuban","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005720083","display_name":"Peter G. Y. Zhang","orcid":"https://orcid.org/0000-0003-0557-3572","observed_orcids":["https://orcid.org/0000-0003-0557-3572"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Zhang","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037891365","display_name":"Mette Krog Josiassen","orcid":"https://orcid.org/0009-0002-2840-9505","observed_orcids":["https://orcid.org/0009-0002-2840-9505"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mette Krog Josiassen","raw_affiliation_strings":["H. Lundbeck A/S, Valby, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Valby, Copenhagen, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023091059","display_name":"Nanco Hefting","orcid":"https://orcid.org/0000-0003-3310-3439","observed_orcids":["https://orcid.org/0000-0003-3310-3439"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nanco Hefting","raw_affiliation_strings":["H. Lundbeck A/S, Valby, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Valby, Copenhagen, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075893378","display_name":"Carole Augustine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carole Augustine","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033150501","display_name":"Claudette Brewer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudette Brewer","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045081626","display_name":"Raymond Sanchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raymond Sanchez","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108358185","display_name":"Robert D. McQuade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert D. McQuade","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA;","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5110533970"],"corresponding_institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"],"apc_list":null,"apc_paid":null,"fwci":3.8306,"has_fulltext":true,"cited_by_count":71,"citation_normalized_percentile":{"value":0.93688567,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"34","issue":"4","first_page":"633","last_page":"642"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.996999979019165},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/inadequate-response-to-antidepressants","display_name":"inadequate response to antidepressants","score":0.8009999990463257},{"id":"https://openalex.org/keywords/quetiapine-extended-release","display_name":"quetiapine extended release","score":0.9660000205039978},{"id":"https://openalex.org/keywords/flexible-dosing","display_name":"flexible dosing","score":0.746999979019165},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.5809999704360962},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9293609857559204},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6251746416091919},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5999734401702881},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.5582990050315857},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5106163620948792},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3933989107608795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28294578194618225},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.19446474313735962},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.1631959080696106},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011595","descriptor_name":"Psychomotor Agitation","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/03007995.2018.1430220","doi":"https://doi.org/10.1080/03007995.2018.1430220","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2018.1430220","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1430220?needAccess=true&role=button","source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:29343128","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29343128","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/03007995.2018.1430220","doi":"https://doi.org/10.1080/03007995.2018.1430220","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2018.1430220","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1430220?needAccess=true&role=button","source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2789214860.pdf","grobid_xml":"https://content.openalex.org/works/W2789214860.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W105014248","https://openalex.org/W1868790909","https://openalex.org/W1993810702","https://openalex.org/W1999689270","https://openalex.org/W2010896339","https://openalex.org/W2012655610","https://openalex.org/W2027061717","https://openalex.org/W2078154303","https://openalex.org/W2084779737","https://openalex.org/W2104518967","https://openalex.org/W2111663098","https://openalex.org/W2115206348","https://openalex.org/W2131823335","https://openalex.org/W2132324173","https://openalex.org/W2138437831","https://openalex.org/W2140725933","https://openalex.org/W2148083007","https://openalex.org/W2151839057","https://openalex.org/W2165379748","https://openalex.org/W2225684373","https://openalex.org/W2340538438","https://openalex.org/W2405974320","https://openalex.org/W2562628019","https://openalex.org/W2565638269","https://openalex.org/W2777439954","https://openalex.org/W3090293687","https://openalex.org/W4243757772","https://openalex.org/W4255396331"],"related_works":["https://openalex.org/W2803445534","https://openalex.org/W1868790909","https://openalex.org/W2957698583","https://openalex.org/W2140725933","https://openalex.org/W2911295141","https://openalex.org/W1979218784","https://openalex.org/W2560018769","https://openalex.org/W4414895110","https://openalex.org/W2565638269","https://openalex.org/W7213450966"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"the":[3,79,90,112,172,189],"efficacy,":[4],"safety,":[5],"and":[6,20,195,213,233,239],"tolerability":[7],"of":[8,188,223],"brexpiprazole":[9,67,123,165,207,218],"as":[10],"adjunctive":[11,133,150,227],"treatment":[12,27,39,49],"in":[13,51,98,114,128,204,229],"adults":[14],"with":[15,31,40,226,231,243],"major":[16,34],"depressive":[17,35],"disorder":[18],"(MDD)":[19],"an":[21,44,234],"inadequate":[22,235],"response":[23,236],"to":[24,58,66,78,95,167,237],"prior":[25,38],"antidepressant":[26],"(ADT).":[28],"METHODS:":[29],"Patients":[30],"a":[32,125],"current":[33],"episode":[36],"after":[37],"1-3":[41],"ADTs":[42],"entered":[43],"8-":[45],"or":[46,71],"10-week":[47],"prospective":[48],"phase":[50],"which":[52],"they":[53],"received":[54],"double-blind":[55],"placebo":[56,134,157,170,228],"adjunct":[57,77],"open-label":[59],"ADT.":[60],"Inadequate":[61],"responders":[62],"were":[63,208],"randomized":[64],"(2:2:1)":[65],"2-3":[68,219],"mg/day,":[69,76],"placebo,":[70],"quetiapine":[72,151],"extended-release":[73],"(XR)":[74],"150-300":[75],"same":[80],"ADT,":[81],"for":[82],"6":[83,97],"weeks.":[84],"The":[85,106,198],"primary":[86],"efficacy":[87,109],"endpoint":[88,110],"was":[89,111,240],"change":[91,113],"from":[92,156,169],"baseline":[93],"(randomization)":[94],"week":[96],"Montgomery-\u00c5sberg":[99],"Depression":[100],"Rating":[101],"Scale":[102,117],"(MADRS)":[103],"total":[104,130],"score.":[105,120],"key":[107],"secondary":[108],"Sheehan":[115],"Disability":[116],"(SDS)":[118],"mean":[119,137,174],"RESULTS:":[121],"Adjunctive":[122,164,217],"showed":[124],"greater":[126],"improvement":[127],"MADRS":[129],"score":[131,175],"than":[132],"(least":[135],"squares":[136],"difference":[138],"[95%":[139],"confidence":[140],"interval]":[141],"=":[142,147,162,180],"-1.48":[143],"[-2.56,":[144],"-0.39];":[145],"p":[146,161,179],".0078),":[148],"whereas":[149],"XR":[152],"did":[153,183],"not":[154],"separate":[155,168],"(-0.30":[158],"[-1.63,":[159],"1.04];":[160],".66).":[163],"failed":[166],"on":[171,186],"SDS":[173,191],"(-0.23":[176],"[-0.52,":[177],"0.07];":[178],".13),":[181],"but":[182],"improve":[184],"functioning":[185],"two":[187],"three":[190],"items":[192],"(family":[193],"life":[194],"social":[196],"life).":[197],"most":[199],"frequent":[200],"treatment-emergent":[201],"adverse":[202],"events":[203],"patients":[205,230],"receiving":[206],"akathisia":[209],"(6.1%),":[210],"somnolence":[211],"(5.6%),":[212],"headache":[214],"(5.6%).":[215],"CONCLUSIONS:":[216],"mg/day":[220],"improved":[221],"symptoms":[222],"depression":[224],"compared":[225],"MDD":[232],"ADTs,":[238],"well":[241],"tolerated":[242],"no":[244],"unexpected":[245],"side":[246],"effects.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2789214860","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-03-06T00:00:00"}
